LYC-55716

· Lycera Corp.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LYC-55716, covering 2019-09-25 to 2019-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]